Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228813 · ClinicalTrials.gov registry record · NA
G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00228813 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 8 participants.
The verdict
NCT00228813, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purposes of this study are: * To examine the engraftment rate in patients receiving in vivo T-cell-depleted G-CSF stimulated bone marrow from partially mismatched related donors. * To evaluate the incidence and severity of acute and chronic graft-versus-host disease in patients receiving in vivo T-cell-depleted G-CSF stimulated bone marrow from partially mismatched related donors.
Interventions
- DRUG Granulocyte Colony Stimulating Factor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-04 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228813
The ClinicalTrials.gov registry entry for NCT00228813 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Granulocyte Colony Stimulating Factor is the first listed.
NCT00228813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228813 about?
NCT00228813 is a clinical study titled "G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome". The purposes of this study are: * To examine the engraftment rate in patients receiving in vivo T-cell-depleted G-CSF stimulated bone marrow from partially mismatched related donors. * To evaluate the incidence and severity of acute and chronic graft-versus-host disease in patients receiving in viv...
What is the current status of trial NCT00228813?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2004-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00228813?
The interventions under investigation include: Granulocyte Colony Stimulating Factor (DRUG).
Who is sponsoring clinical trial NCT00228813?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.